Opinion - Modulation of the immunological synapse: A key to HIV-1 pathogenesis?

Nature Reviews Immunology

Volumn 7, Issue 4, 2007, Pages 310-317

  Fackler, Oliver T ^a   Alcover, Andres ^b   Schwartz, Olivier ^b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

NEF PROTEIN; T LYMPHOCYTE RECEPTOR; LYMPHOCYTE ANTIGEN RECEPTOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIGEN PRESENTING CELL; APOPTOSIS; CD4+ T LYMPHOCYTE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNE SYSTEM; IMMUNOMODULATION; IMMUNOPATHOGENESIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; VIRUS VIRULENCE; ANIMAL; CELL COMMUNICATION; IMMUNOLOGY; PROTEIN TRANSPORT;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANIMALS; ANTIGEN-PRESENTING CELLS; CD4-POSITIVE T-LYMPHOCYTES; CELL COMMUNICATION; GENE PRODUCTS, NEF; HIV-1; HUMANS; PROTEIN TRANSPORT; RECEPTOR CROSS-TALK; RECEPTORS, ANTIGEN, T-CELL;

EID: 33947591273     PISSN: 14741733     EISSN: None     Source Type: Journal    
DOI: 10.1038/nri2041     Document Type: Review

References (103)

1. Stevenson, M. HIV-1 pathogenesis. Nature Med. 9, 853-860 (2003).
2. Zack, J. A. et al. HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure. Cell 61, 213-222 (1990).
3. Bukrinsky, M. I., Stanwick, T. L., Dempsey, M. P. & Stevenson, M. Quiescent T lymphocytes as an inducible virus reservoir in HIV-1 infection. Science 254, 423-427 (1991).
4. Stevenson, M., Stanwick, T. L., Dempsey, M. P. & Lamonica, C. A. HIV-1 replication is controlled at the level of T cell activation and proviral integration. EMBO J. 9, 1551-1560 (1990).
5. Spina, C. A., Guatelli, J. C. & Richman, D. D. Establishment of a stable, inducible form of human immunodeficiency virus type 1 DNA in quiescent CD4 lymphocytes in vitro. J. Virol. 69, 2977-2988 (1995).
6. + T cells. PLoS Pathog. 2, e68 (2006).
7. Williams, S. A. et al. NF-κB p50 promotes HIV latency through HDAC recruitment and repression of transcriptional initiation. EMBO J. 25, 139-149 (2006).
8. Jordan, A., Bisgrove, D. & Verdin, E. HIV reproducibly establishes a latent infection after acute infection of T cells in vitro. EMBO J. 22, 1868-1877 (2003).
9. Tong-Starksen, S. E., Luciw, P. A. & Peterlin, B. M. Human immunodeficiency virus long terminal repeat responds to T-cell activation signals. Proc. Natl Acad. Sci. USA 84, 6845-6849 (1987).
10. Adams, M. et al. Cellular latency in human immunodeficiency virus-infected individuals with high CD4 levels can be detected by the presence of promoter-proximal transcripts. Proc. Natl Acad. Sci. USA 91, 3862-3866 (1994).
11. + T cells. Nature 435, 108-114 (2005).
12. Kreisberg, J. F., Yonemoto, W. & Greene, W. C. Endogenous factors enhance HIV infection of tissue naive CD4 T cells by stimulating high molecular mass APOBEC3G complex formation. J. Exp. Med. 203, 865-870 (2006).
13. Kinoshita, S., Chen, B. K., Kaneshima, H. & Nolan, G. P. Host control of HIV-1 parasitism in T cells by the nuclear factor of activated T cells. Cell 95, 595-604 (1998).
14. + lymphocytes. Nature 426, 853-857 (2003).
15. + T cell decline. Proc. Natl Acad. Sci. USA 97, 1269-1274 (2000).
16. + T cells are infected in human immunodeficiency virus type 1-infected individuals. J. Virol. 73, 6430-6435 (1999).
17. + T cells. Science 286, 1353-1357 (1999).
18. Haase, A. T. Perils at mucosal front lines for HIV and SIV and their hosts. Nature Rev. Immunol. 5, 783-792 (2005).
19. + T cells residing within human lymphoid tissues. Immunity 15, 671-682 (2001).
20. + T cells lacking activation markers support HIV replication during immune activation. J. Immunol. 166, 6437-6443 (2001).
21. Unutmaz, D., KewalRamani, V. N., Marmon, S. & Littman, D. R. Cytokine signals are sufficient for HIV-1 infection of resting human T lymphocytes. J. Exp. Med. 189, 1735-1746 (1999).
22. Arnold, R., Brenner, D., Becker, M., Frey, C. R. & Krammer, P. H. How T lymphocytes switch between life and death. Eur. J. Immunol. 36, 1654-1658 (2006).
23. Bourgeois, C. & Stockinger, B. T cell homeostasis in steady state and lymphopenic conditions. Immunol. Lett. 107, 89-92 (2006).
24. Baur, A. S. et al. HIV-1 Nef leads to inhibition or activation of T cells depending on its intracellular localization. Immunity 1, 373-384 (1994).
25. Simmons, A., Aluvihare, V. & McMichael, A. Nef triggers a transcriptional program in T cells imitating single-signal T cell activation and inducing HIV virulence mediators. Immunity 14, 763-777 (2001).
26. Wolf, D. et al. HIV-1 Nef associated PAK and PI3-kinases stimulate Akt-independent Bad-phosphorylation to induce anti-apoptotic signals. Nature Med. 7, 1217-1224 (2001).
27. Wu, Y. & Marsh, J. W. Selective transcription and modulation of resting T cell activity by preintegrated HIV DNA. Science 293, 1503-1506 (2001).
28. Geleziunas, R., Xu, W., Takeda, K., Ichijo, H. & Greene, W. C. HIV-1 Nef inhibits ASK1-dependent death signalling providing a potential mechanism for protecting the infected host cell. Nature 410, 834-838 (2001).
29. + T lymphocytes by the Nef protein of HIV-1. J. Leukoc. Biol. 79, 616-627 (2006).
30. Ott, M. et al. Immune hyperactivation of HIV-1-infected T cells mediated by Tat and the CD28 pathway. Science 275, 1481-1485 (1997).
31. Williams, S. A. & Greene, W. C. Host factors regulating post-integration latency of HIV. Trends Microbiol. 13, 137-139 (2005).
32. Dimitrov, D. S. et al. Quantitation of human immunodeficiency virus type 1 infection kinetics. J. Virol. 67, 2182-2190 (1993).
33. Jolly, C., Kashefi, K., Hollinshead, M. & Sattentau, Q. J. HIV-1 cell to cell transfer across an Env-induced, actin-dependent synapse. J. Exp. Med. 199, 283-293 (2004).
34. Phillips, D. M. The role of cell-to-cell transmission in HIV infection. AIDS 8, 719-731 (1994).
35. Piguet, V. & Sattentau, Q. Dangerous liaisons at the virological synapse. J. Clin. Invest. 114, 605-610 (2004).
36. Sol-Foulon, N. et al. ZAP-70 kinase regulates HIV cell-to-cell spread and virological synapse formation. EMBO J. 26, 516-526 (2007).
37. Thoulouze, M. I. et al. Human immunodeficiency virus type-1 infection impairs the formation of the immunological synapse. Immunity 24, 547-561 (2006).
38. Haller, C. et al. The HIV-1 pathogenicity factor Nef interferes with maturation of stimulatory T-lymphocyte contacts by modulation of N-Wasp activity. J. Biol. Chem. 281, 19618-19630 (2006).
39. Fenard, D. et al. Nef is physically recruited into the immunological synapse and potentiates T cell activation early after TCR engagement. J. Immunol. 175, 6050-6057 (2005).
40. Deacon, N. J. et al. Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients. Science 270, 988-991 (1995).
41. Kestler, H. W. 3rd, et al. Importance of the nef gene for maintenance of high virus loads and for development of AIDS. Cell 65, 651-662 (1991).
42. Kirchhoff, F., Greenough, T. C., Brettler, D. B., Sullivan, J. L. & Desrosiers, R. C. Brief report: absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection. N. Engl. J. Med. 332, 228-232 (1995).
43. Geyer, M., Fackler, O. T. & Peterlin, B. M. Structure-function relationships in HIV-1 Nef. EMBO Rep. 2, 580-585 (2001).
44. Greene, W. C. & Peterlin, B. M. Charting HIV's remarkable voyage through the cell: Basic science as a passport to future therapy. Nature Med. 8, 673-680 (2002).
45. Tolstrup, M., Ostergaard, L., Laursen, A. L., Pedersen, S. F. & Duch, M. HIV/SIV escape from immune surveillance: focus on Nef. Curr. HIV Res. 2, 141-151 (2004).
46. Roeth, J. F. & Collins, K. L. Human immunodeficiency virus type 1 Nef: adapting to intracellular trafficking pathways. Microbiol. Mol. Biol. Rev. 70, 548-563 (2006).
47. Fackler, O. T. et al. A natural variability in the prolinerich motif of Nef modulates HIV-1 replication in primary T cells. Curr. Biol. 11, 1294-1299 (2001).
48. Messmer, D., Ignatius, R., Santisteban, C., Steinman, R. M. & Pope, M. The decreased replicative capacity of simian immunodeficiency virus SIVmac239Δnef is manifest in cultures of immature dendritic cells and T cells. J. Virol. 74, 2406-2413 (2000).
49. Petit, C. et al. Nef is required for efficient HIV-1 replication in cocultures of dendritic cells and lymphocytes. Virology 286, 225-236 (2001).
50. + T cells in a Nef-dependent manner in vitro and in vivo. J. Virol. 79, 264-276 (2005).
51. Choi, J. et al. Endothelial cells promote human immunodeficiency virus replication in nondividing memory T cells via Nef-, Vpr-, and T-cell receptor-dependent activation of NFAT. J. Virol. 79, 11194-11204 (2005).
52. Glushakova, S. et al. Nef enhances human immunodeficiency virus replication and responsiveness to interleukin-2 in human lymphoid tissue ex vivo. J. Virol. 73, 3968-3974 (1999).
53. Friedl, P., den Boer, A. T. & Gunzer, M. Tuning immune responses: diversity and adaptation of the immunological synapse. Nature Rev. Immunol. 5, 532-545 (2005).
54. Sancho, D. et al. TCR engagement induces proline-rich tyrosine kinase-2 (Pyk2) translocation to the T cell-APC interface independently of Pyk2 activity and in an immunoreceptor tyrosine-based activation motif-mediated fashion. J. Immunol. 169, 292-300 (2002).
55. Holdorf, A. D., Lee, K. H., Burack, W. R., Allen, P. M. & Shaw, A. S. Regulation of Lck activity by CD4 and CD28 in the immunological synapse. Nature Immunol. 3, 259-264 (2002).
56. Li, Q. J. et al. CD4 enhances T cell sensitivity to antigen by coordinating Lck accumulation at the immunological synapse. Nature Immunol. 5, 791-799 (2004).
57. + T cells requires Nef and Tat virus gene products and results from higher NFAT, NF-κB, and AP-1 induction. J. Biol. Chem. 279, 39520-39531 (2004).
58. Manninen, A., Huotari, P., Hiipakka, M., Renkema, G. H. & Saksela, K. Activation of NFAT-dependent gene expression by Nef: conservation among divergent Nef alleles, dependence on SH3 binding and membrane association, and cooperation with protein kinase C-θ. J. Virol. 75, 3034-3037 (2001).
59. Schrager, J. A. & Marsh, J. W. HIV-1 Nef increases T cell activation in a stimulus-dependent manner. Proc. Natl Acad. Sci. USA 96, 8167-8172 (1999).
60. Wang, J. K., Kiyokawa, E., Verdin, E. & Trono, D. The Nef protein of HIV-1 associates with rafts and primes T cells for activation. Proc. Natl Acad. Sci. USA 97, 394-399 (2000).
61. Alcover, A. & Alarcon, B. Internalization and intracellular fate of TCR-CD3 complexes. Crit. Rev. Immunol. 20, 325-346 (2000).
62. Naramura, M. et al. c-Cbl and Cbl-b regulate T cell responsiveness by promoting ligand-induced TCR down-modulation. Nature Immunol. 3, 1192-1199 (2002).
63. Valitutti, S., Muller, S., Salio, M. & Lanzavecchia, A. Degradation of T cell receptor (TCR)-CD3-ζ complexes after antigenic stimulation. J. Exp. Med. 185, 1859-1864 (1997).
64. Das, V. et al. Activation-induced polarized recycling targets T cell antigen receptors to the immunological synapse; involvement of SNARE complexes. Immunity 20, 577-588 (2004).
65. Varma, R., Campi, G., Yokosuka, T., Saito, T. & Dustin, M. L. T cell receptor-proximal signals are sustained in peripheral microclusters and terminated in the central supramolecular activation cluster. Immunity 25, 117-127 (2006).
66. Ehrlich, L. I., Ebert, P. J., Krummel, M. F., Weiss, A. & Davis, M. M. Dynamics of p56lck translocation to the T cell immunological synapse following agonist and antagonist stimulation. Immunity 17, 809-822 (2002).
67. Salghetti, S., Mariani, R. & Skowronski, J. Human immunodeficiency virus type 1 Nef and p56lck protein-tyrosine kinase interact with a common element in CD4 cytoplasmic tail. Proc. Natl Acad. Sci. USA 92, 349-353 (1995).
68. D'Oro, U., Vacchio, M. S., Weissman, A. M. & Ashwell, J. D. Activation of the Lck tyrosine kinase targets cell surface T cell antigen receptors for lysosomal degradation. Immunity 7, 619-628 (1997).
69. Simmons, A. et al. Nef-mediated lipid raft exclusion of UbcH7 inhibits Cbl activity in T cells to positively regulate signaling. Immunity 23, 621-634 (2005).
70. + T lymphocytes. Virology 336, 219-228 (2005).
71. Campbell, E. M., Nunez, R. & Hope, T. J. Disruption of the actin cytoskeleton can complement the ability of Nef to enhance human immunodeficiency virus type 1 infectivity. J. Virol. 78, 5745-5755 (2004).
72. Fackler, O. T., Luo, W., Geyer, M., Alberts, A. S. & Peterlin, B. M. Activation of Vav by Nef induces cytoskeletal rearrangements and downstream effector functions. Mol. Cell 3, 729-739 (1999).
73. Quaranta, M. G. et al. HIV-1 Nef triggers Vav-mediated signaling pathway leading to functional and morphological differentiation of dendritic cells. FASEB J. 17, 2025-2036 (2003).
74. Snapper, S. B. et al. Wiskott-Aldrich syndrome protein-deficient mice reveal a role for WASP in T but not B cell activation. Immunity 9, 81-91 (1998).
75. Zhang, J. et al. Antigen receptor-induced activation and cytoskeletal rearrangement are impaired in Wiskott-Aldrich syndrome protein-deficient lymphocytes. J. Exp. Med. 190, 1329-1342 (1999).
76. Arora, V. K. et al. Lentivirus Nef specifically activates Pak2. J. Virol. 74, 11081-11087 (2000).
77. Renkema, G. H., Manninen, A., Mann, D. A., Harris, M. & Saksela, K. Identification of the Nef-associated kinase as p21-activated kinase 2. Curr. Biol. 9, 1407-1410 (1999).
78. Krautkramer, E., Giese, S. I., Gasteier, J. E., Muranyi, W. & Fackler, O. T. Human immunodeficiency virus type 1 Nef activates p21-activated kinase via recruitment into lipid rafts. J. Virol. 78, 4085-4097 (2004).
79. Pulkkinen, K., Renkema, G. H., Kirchhoff, F. & Saksela, K. Nef associates with p21-activated kinase 2 in a p21-GTPase-dependent dynamic activation complex within lipid rafts. J. Virol. 78, 12773-12780 (2004).
80. Monjas, A., Alcover, A. & Alarcon, B. Engaged and bystander T cell receptors are down-modulated by different endocytotic pathways. J. Biol. Chem. 279, 55376-55384 (2004).
81. McGavin, M. K. et al. The intersectin 2 adaptor links Wiskott Aldrich syndrome protein (WASp)-mediated actin polymerization to T cell antigen receptor endocytosis. J. Exp. Med. 194, 1777-1787 (2001).
82. Chang, F. S., Han, G. S., Carman, G. M. & Blumer, K. J. A WASp-binding type II phosphatidylinositol 4-kinase required for actin polymerization-driven endosome motility. J. Cell Biol. 171, 133-142 (2005).
83. Chang, F. S., Stefan, C. J. & Blumer, K. J. A WASp homolog powers actin polymerization-dependent motility of endosomes in vivo. Curr. Biol. 13, 455-463 (2003).
84. Taunton, J. et al. Actin-dependent propulsion of endosomes and lysosomes by recruitment of N-WASP. J. Cell Biol. 148, 519-530 (2000).
85. Schindler, M. et al. Nef-mediated suppression of T cell activation was lost in a lentiviral lineage that gave rise to HIV-1. Cell 125, 1055-1067 (2006).
86. Bell, I. et al. Association of simian immunodeficiency virus Nef with the T-cell receptor (TCR) ζ chain leads to TCR down-modulation. J. Gen. Virol. 79, 2717-2727 (1998).
87. Howe, A. Y., Jung, J. U. & Desrosiers, R. C. ζ chain of the T-cell receptor interacts with nef of simian immunodeficiency virus and human immunodeficiency virus type 2. J. Virol. 72, 9827-9834 (1998).
88. Xu, X. N. et al. Induction of Fas ligand expression by HIV involves the interaction of Nef with the T cell receptor ζ chain. J. Exp. Med. 189, 1489-1496 (1999).
89. Swingler, S. et al. HIV-1 Nef mediates lymphocyte chemotaxis and activation by infected macrophages. Nature Med. 5, 997-1003 (1999).
90. Messmer, D. et al. Endogenously expressed nef uncouples cytokine and chemokine production from membrane phenotypic maturation in dendritic cells. J. Immunol. 169, 4172-4182 (2002).
91. Briggs, S. D. et al. HIV-1 Nef promotes survival of myeloid cells by a STAT3-dependent pathway. J. Biol. Chem. 276, 25605-25611 (2001).
92. Percario, Z. et al. Human immunodeficiency virus type 1 (HIV-1) Nef activates STAT3 in primary human monocyte/macrophages through the release of soluble factors: involvement of Nef domains interacting with the cell endocytotic machinery. J. Leukoc. Biol. 74, 821-832 (2003).
93. Swingler, S. et al. HIV-1 Nef intersects the macrophage CD40L signalling pathway to promote resting-cell infection. Nature 424, 213-219 (2003).
94. Hayes, S. M. & Love, P. E. Strength of signal: a fundamental mechanism for cell fate specification. Immunol. Rev. 209, 170-175 (2006).
95. Hugues, S. et al. Distinct T cell dynamics in lymph nodes during the induction of tolerance and immunity. Nature Immunol. 5, 1235-1242 (2004).
96. Langenkamp, A. et al. T cell priming by dendritic cells: thresholds for proliferation, differentiation and death and intraclonal functional diversification. Eur. J. Immunol. 32, 2046-2054 (2002).
97. Viola, A. & Lanzavecchia, A. T cell activation determined by T cell receptor number and tunable thresholds. Science 273, 104-106 (1996).
98. Bousso, P. & Robey, E. A. Dynamic behavior of T cells and thymocytes in lymphoid organs as revealed by two-photon microscopy. Immunity 21, 349-355 (2004).
99. Collins, K. L., Chen, B. K., Kalams, S. A., Walker, B. D. & Baltimore, D. HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes. Nature 391, 397-401 (1998).
100. Schwartz, O., Marechal, V., Le Gall, S., Lemonnier, F. & Heard, J. M. Endocytosis of major histocompatibility complex class I molecules is induced by the HIV-1 Nef protein. Nature Med. 2, 338-342 (1996).
101. Sourisseau, M., Sol-Foulon, N., Porrot, F., Blanchet, F. & Schwartz, O. Inefficient HIV replication in mobile lymphocytes. J. Virol. 81, 1000-1012 (2007).
102. Sugimoto, C. et al. nef gene is required for robust productive infection by simian immunodeficiency virus of T-cell-rich paracortex in lymph nodes. J. Virol. 77, 4169-4180 (2003).
103. Roumier, A. et al. The membrane-microfilament linker ezrin is involved in the formation of the immunological synapse and in T cell activation. Immunity 15, 715-728 (2001).